Asthma & Allergy

Enterovirus infections are associated with reduced risk of allergic sensitization. This effect is most likely mediated by the stimulation of the regulatory elements of the immune system. Vactech owns patented innovations covering the use of virus-like particles (VLP) to stimulate these regulatory pathways in order to prevent and cure allergic diseases (IMAVAC™ technology).